Anthony Bahinski, Global Head, Safety Pharmacology

GlaxoSmithKline

Phone :

Adress : -

Dr. Anthony Bahinski is Global Head of Safety Pharmacology at GlaxoSmithKline. Prior to joining GlaxoSmithKline, he was a member of the Advanced Technology Team at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he led development of novel Organ-on-a-Chip technologies for more predictive in vitro assays for safety and efficacy of drugs, vaccines and biologics. Dr. Bahinski’s career spans academic research and large Pharma, with over 19 years’ experience in the pharmaceutical industry (including P&G, Pharmacia, Pfizer). Dr. Bahinski received his PhD in Physiology from Temple University, Philadelphia, PA and his MBA from Xavier University, Cincinnati, OH. He completed post docs at Rockefeller University and the University of Cincinnati. Dr. Bahinski has served on several advisory boards and is a current member of the Science Board of the United States Food and Drug Administration, the EPA’s Board of Scientific Counselors (BOSC), member of EU H2020 ORgan-on-Chip In Development (ORCHID) Advisory Board and former member of the Board of Directors of the Safety Pharmacology Society. He is a member of the Editorial Board of the journals, Applied In Vitro Toxicology and Frontiers in Pharmacology of Ion Channels and Channelopathies. He has served on Peer Review Panels at the NIH, EPA and NCI SBIR. He has served the Society of Toxicology as Councilor (Executive Committee) of the Drug Discovery Toxicology Specialty Section and is current Vice President-Elect of the Cardiovascular Toxicology Specialty Section. He is author/co-author of 42 publications including peer-reviewed articles and book chapters.

External link

News & announcement

Become a member

You are not a member yet? Subscribe here to join the OoC community.

Join us

Stay tuned

Become a member
WHAT IS THE ADVANTAGE OF JOINING THE OoC COMMUNITY ? registration

Academic

  • Keep up to date on the latest news and events
  • Share information
  • Find expertise/collaboration

 

Industrial

  • Keep informed about new scientific and technological developments
  • Find academic/private partners
  • Gain in visibility and awareness of your activity

Individual

  • Get a better understanding of OoC field (applications, challenges)
  • Be updated about OoC
  • Be part of the network

Sentence about data protection vocabulo circulo abdita lunari semper theologi etiam alii filiam duplici.

Academic

Keep up to date on the latest news and events

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Industrial

Keep informed about new scientific and technological developments

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Individual

Be updated about OoC / Get a better understanding of OoC

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Reserved
ACCESS

Return
Join us !

Would you like to know more ?
Join us and share the latest advances in OoC Research, be informed about emerging OoC projects, about who are the European leading experts, the novel applications, partners and much more

(Note: free membership gives you access to the library)

OR

Connect to your personal space

Forgot your password?
OR